The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.

While Quantum computing has been reported to be five years away for many years now, companies are preparing for it by setting ...

Intrepid Labs’ Valiant platform uses AI and robotics to cut drug formulation timelines from months to days Over $11M USD ...

This article is authored by Aditya Sharma, head, Process Solutions, India Region, Merck Life Science, New Delhi.

Orphan drug developers face significant difficulties when navigating market access frameworks in Europe. Could greater use of ...

OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

The US Food and Drug Administration (FDA) has announced that all its centres will operate on a common generative artificial ...